The FDA has submitted an 'Interim Access Policy' on peptide drugs to the White House for review, according to people familiar with the matter cited by the Associated Press. The policy would reportedly let the agency decline to enforce existing restrictions on certain peptides, reassuring compounding pharmacies that they won't face enforcement action if they begin producing them. This comes as FDA scientists are re-reviewing a dozen peptide drugs previously found in 2023 to lack sufficient safety and efficacy data.
arstechnica.com
· 2026-10-16
At the Make America Healthy Again Conference, Health Secretary Robert F. Kennedy Jr. told Vice President JD Vance that AI chatbots are now 'better informed' than human physicians, according to the New York Times. He said AI could let ordinary Americans challenge public health guidance on masks, social distancing and vaccines, and claimed OpenAI CEO Sam Altman told him it would be 'malpractice' for a doctor to prescribe without consulting AI first.
futurism.com
· 2026-09-30
A wave of wellness influencers, podcasters and tech startups are promoting nicotine—often via pouches or products combined with caffeine and nootropics—as a natural compound that boosts focus and guards against cognitive decline. A pulmonary physician-scientist who studies nicotine addiction says these claims stretch limited findings from cognition studies far beyond what human research actually supports.
wired.com
· 2026-09-27